Dermatological adverse events due to oncotherapy: the necessity for a new classification
Saved in:
| Main Authors: | A. Pagani, G. Caro, H. Beltraminelli, C. Mangas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | EJC Skin Cancer |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S277261182400137X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Porous egg microparticles for controllable drug delivery and oncotherapy
by: Dan Yan, et al.
Published: (2025-03-01) -
Colorectal cancer spectrum: From subtypes and epidemiology to oncotherapies
by: Nidhi Agrawal, et al.
Published: (2025-04-01) -
Pretheranostic agents with extraordinaryNIRF/photoacoustic imaging performanceand photothermal oncotherapy efficacy
by: Liu Shi, et al.
Published: (2024-12-01) -
Impact of Lidocaine Concentration on Analgesic Efficacy and Adverse Events in Dermatologic Infiltrative Anesthesia
by: Van Thanh Le Thai, et al.
Published: (2025-07-01) -
Evaluation of anticancer therapy- related dermatologic adverse events: insights from fda's faers dataset
by: S. Salah, et al.
Published: (2024-01-01)